Advanced Certificate in Ketamine-Assisted Psychotherapy
The Certificate in Ketamine-Assisted Psychotherapy trains clinicians in ethical, practical, and business aspects of ketamine therapy for effective client support.
Course Overview
The Certificate in Ketamine-Assisted Psychotherapy (KAP) is a detailed training program designed for licensed clinicians. This course offers an in-depth exploration of the use of ketamine in psychotherapy, emphasizing ethical considerations, informed consent, and best practices for administration and integration. Participants will gain hands-on experience through live online sessions, roleplays, and case-based learning, ensuring they are well-prepared to support clients through the entire therapeutic process.
The curriculum spans twelve weeks and covers a wide range of topics including the psychological and neurobiological effects of ketamine, preparation and dosing protocols, and strategies for effective integration. Weekly sessions include practical exercises and demonstrations to solidify understanding and application. Additionally, the course provides valuable resources such as video demonstrations and peer learning opportunities to enhance the learning experience.
Participants will also receive guidance on the business aspects of ketamine therapy, including how to establish a practice and collaborate with prescribers. By the end of the program, clinicians will be equipped with the necessary skills and knowledge to effectively and ethically integrate ketamine-assisted psychotherapy into their practice, addressing common challenges and maximizing therapeutic outcomes for their clients.
Who is this for?
Licensed clinicians
Prerequisites
Licensed clinician
About the Provider
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
View Fluence profileCourse Details
- Price$3,000
- FormatLive Classes
- Lifecycle statusNo New Dates
- Skillsketamine-assisted therapist trainingfacilitating ketamine therapyhelping patients decide if treatment is recommendedKetamine-assisted psychotherapyEthical practiceInformed consentAdministration protocolsIntegration supportPreparation and dosingClient care planningCollaboration with prescribersPractice setup
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesAdd Spravato® To Your Practice with our 8-Phases Implementation Roadmap
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).
Certificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Curriculum
A curriculum focused on psilocybin, MDMA, and ketamine facilitation for spiritual and psychotherapeutic care. It was grounded in inclusion, reciprocity, and respect, and combined scientific, ancestral, and communal perspectives.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).